FindTrial
Sign In

Association of dietary pattern with advanced glycation end products (AGEs) and high senstivity C reactive protein (hs-CRP) in patients of MADHUMEHA w. s. r to Type II Diabetes Mellitus.

Association of dietary pattern with advanced glycation end products and high senstivity C reactive protein in patients of MADHUMEHA w. s. r to Type II Diabetes Mellitus. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082853
Enrollment
100
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type II DM for 1 year controlled and uncontrolled. Age range of 21 years and above. HbA1c range -6.5% to 9.5%.

Exclusion criteria

Exclusion criteria: Severe hypoglycemic episode (requiring assistance) during the last 3 months. Pregnant women. Patients with- severe diabetes complications. Hyperglycemia-induced ketoacidosis in the last month other autoimmune diseases such as celiac disease. Reported energy intake out of 800-4200 kcal were exclude.

Design outcomes

Primary

MeasureTime frame
The association between dietary patterns and levels of Advanced glycation end products and high-sensitivity C-reactive protein with madhumeha (Diabetes Mellitus) relative to Type II DM. Timepoint: At baseline, 4 week, 8 week—

Secondary

MeasureTime frame
Overall improvement in the quality of life Timepoint: At baseline, 4 week, 8 week—

Countries

India

Contacts

Public ContactDr Shivakumar S Harti

All India Institute Of Ayurveda Gautampuri Sarita Vihar New Delhi South DELHI 110076 India

shivkumar.harti@aiia.gov.in9611275434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026